What drove the intraday fall in 2228.HK stock today?

The stock fell on 12 Jan 2026 amid heavy selling and profit‑taking after a rally. Volume hit **95,776,094** shares. Traders cited valuation pressure and rotation in healthcare AI names, plus technical resistance near **HK$11.00**.

How does XtalPi’s valuation compare with peers for 2228.HK stock?

2228.HK shows a high premium: **P/S 70.92** and **P/B 6.04**, well above Hong Kong healthcare averages. That premium reflects investor expectations for AI‑driven revenue growth and licensing wins.

What price targets should investors watch for 2228.HK stock?

Near‑term traders can use **HK$11.50** as a tactical upside target and **HK$9.80** as support. Meyka AI’s 12‑month model projects **HK$9.94** and a 3‑year projection of **HK$13.52**.

When is XtalPi’s next earnings announcement for 2228.HK stock?

The next earnings announcement is scheduled for **27 Mar 2026**. Investors should review that report for revenue cadence, partnership updates, and cash flow trends before repositioning.

HK Stocks

2228.HK XtalPi down 7.93% to HK$10.45 on 12 Jan 2026 (HKSE): AI deals eyed

ByDanny Kontos January 12, 2026January 12, 2026

The 2228.HK stock dropped -7.93% intraday to HK$10.45 on 12 Jan 2026 as trading surged. Volume reached 95,776,094 shares versus an average of 78,890,617. The move follows strong sector rotation into healthcare AI and profit-taking after a sharp 3‑month rally. We review fundamentals, technicals, and model forecasts for XtalPi Holdings Ltd (2228.HK) on the HKSE in Hong Kong.